---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-24-005817"
form_type: "8-K"
ticker: "BGLC"
cik: "0001737523"
company_name: "BioNexus Gene Lab Corp"
filed_at: "2024-09-18T23:59:59+00:00"
generated_at: "2026-05-31T03:59:34.428513+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioNexus Gene Lab subsidiary signs outsourcing deal with Vitarray for mRNA detection in SE Asia

## Summary
- Agreement for mRNA dynamic gene detection services targeting Southeast Asian market.
- Vitarray, authorized by China's Huaxia Jingdu Renhe, supplies samples; MRNA Scientific handles testing.
- MRNA Scientific expects testing cost reduction >25%, boosting profitability.
- Initial batch of experimental tests to be conducted before long-term collaboration.
- Aims to enhance early disease detection for cancer and cardiovascular conditions.

## SEC filing metadata
- accession: 0001477932-24-005817
- form_type: 8-K
- ticker: BGLC
- cik: 0001737523
- company_name: BioNexus Gene Lab Corp
- filed_at: 2024-09-18T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737523/000147793224005817/0001477932-24-005817-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737523/000147793224005817/bglc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-24-005817
- JSON: https://secwatch.observer/filing/0001477932-24-005817.json
- Plain text: https://secwatch.observer/filing/0001477932-24-005817.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.